Oligodendrogliomas occur primarily in the cerebral hemispheres of adults. A rare case of an oligodendroglioma in the cerebellum of a child is presented. The tendency for oligodendroglioma to metastasize through the cerebrospinal fluid (CSF) is reviewed and emphasized. A recommendation for CSF cytology and possible spinal axis irradiation in the treatment of oligodendrogliomas is made.

Download full-text PDF

Source
http://dx.doi.org/10.1227/00006123-198005000-00010DOI Listing

Publication Analysis

Top Keywords

cerebellar oligodendroglioma
4
oligodendroglioma child
4
child oligodendrogliomas
4
oligodendrogliomas occur
4
occur cerebral
4
cerebral hemispheres
4
hemispheres adults
4
adults rare
4
rare case
4
case oligodendroglioma
4

Similar Publications

Intraoperative magnetic resonance imaging (iMRI) is a powerful tool used to verify maximal safe resection of gliomas. However, unsuspected new or incidental findings can present difficult clinical scenarios. Here we present a case of a large supratentorial glioma resection where new, incidental bilateral cerebellar hemispheric enhancement was noted on iMRI.

View Article and Find Full Text PDF

Introduction: Diffuse leptomeningeal glioneuronal tumor (DLGNT), a new addition to the 2016 World Health Organization (WHO) classification, is a rare childhood neoplasm presenting with disseminated leptomeningeal enhancement and an occasional intraparenchymal mass. Diagnosis is often impeded by infectious/immunological differentials, necessitating a biopsy to confirm the diagnosis. We report an adult male with DLGNT without hydrocephalus, which is rare in patients with cerebellar masses.

View Article and Find Full Text PDF

Background: Distant recurrence can occur by infiltration along white matter tracts or dissemination through the cerebrospinal fluid (CSF). This study aimed to clarify the clinical features and mechanisms of recurrence in the dentate nucleus (DN) in patients with supratentorial gliomas. Based on the review of our patients, we verified the hypothesis that distant DN recurrence from a supratentorial lesion occurs through the dentato-rubro-thalamo-cortical (DRTC) pathway.

View Article and Find Full Text PDF
Article Synopsis
  • Antibody-drug conjugates (ADCs) are designed to deliver chemotherapeutic agents to specific cancer cells, and recent research shows that even low levels of target proteins like HER2 can lead to effective treatment in certain brain tumors.
  • A study analyzing gene expression data from over 500 CNS tumors revealed that various tumor types express different ADC targets, with ependymomas having high HER2 levels, while meningiomas and other tumors exhibited specific patterns of target protein expression.
  • The findings suggest that understanding the unique expression profiles of ADC targets in CNS tumors can guide future treatment strategies and help develop new therapies tailored for specific cancer types.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!